Skip to main content

Ascribe Bioscience

Ithaca, United States

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.

$12.0M raised
Oct 2025
Series A

Top Investors

National Science FoundationCultivation CapitalThe Yield LabAcre Venture PartnersCreative Destruction Lab (CDL)

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ascribe Bioscience

How much funding has Ascribe Bioscience raised?
Ascribe Bioscience has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Who are Ascribe Bioscience's investors?
Ascribe Bioscience's investors include National Science Foundation, Cultivation Capital, The Yield Lab, Acre Venture Partners, Creative Destruction Lab (CDL).
Where is Ascribe Bioscience headquartered?
Ascribe Bioscience is headquartered in Ithaca, United States.
What does Ascribe Bioscience do?
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.
What stage is Ascribe Bioscience at?
Ascribe Bioscience is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ascribe Bioscience — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/ascribe-bioscience. Accessed June 4, 2026.
APA
VCBacked. (2025). Ascribe Bioscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ascribe-bioscience
Wikipedia (cite web)
{{cite web |title=Ascribe Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/ascribe-bioscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .